DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
molnupiravir - 2 Francis Crick - 2 Merck - 2 ” Theo Sanderson - 1 Theo Sanderson - 1 Covid - 1 Merck's molnupiravir - 1 Molnupiravir - 1
Top related locs:
London molnupiravir U.S
Top related orgs:
Francis - 2 Francis Crick Institute - 2 Nature - 1 Twitter - 1 Merck - 1 U.S . Food - 1 Drug Administration - 1 FDA - 1

Search resuls for: "Theo Sanderson"


2 mentions found


☆ Study: Merck’s COVID-19 Drug Linked to Mutated Coronavirus Strains
  + stars: | 2023-09-26 | by ( Cecelia Smith-Schoenwalder | Sept. | At P.M. | ) www.usnews.com   time to read: +2 min
A study published this week linked the COVID-19 antiviral molnupiravir to new coronavirus mutations, raising questions about whether the drug could lead to the evolution of potentially concerning strains in the future. The drug works by causing mutations in the genetic information of the virus. Researchers looked at 15 million coronavirus genomes to analyze the timing and type of mutations. Study authors said the findings are important for regulators who assess the drug. “The authors assume these mutations were associated with viral spread from molnupiravir-treated patients without documented evidence of that transmission.
Persons: molnupiravir, ” Theo Sanderson, Francis Crick, Merck Organizations: Nature, Francis, Francis Crick Institute Locations: London, molnupiravir
☆ Merck Covid drug linked to virus mutations that can spread between people, new study says
  + stars: | 2023-09-25 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +3 min
A new study released Monday said Merck 's widely used antiviral Covid pill can cause mutations in the virus that occasionally spread to other people, raising questions about whether the drug has the potential to accelerate Covid's evolution. Molnupiravir works by causing mutations in Covid's genetic information, which weakens or destroys the virus and reduces the amount of Covid in the body. Researchers in the U.S. and U.K. specifically analyzed 15 million Covid genomes to see which mutations had occurred and when. Based on data at the time, a spokesperson for Merck said it didn't believe molnupiravir was likely to contribute to Covid mutations. The new study comes as Covid once again gains a stronger foothold in the U.S., primarily driven by newer strains of the virus.
Persons: Merck, molnupiravir, Theo Sanderson, Francis Crick, Covid, Merck's molnupiravir, Molnupiravir Organizations: Francis, Francis Crick Institute, Twitter, Merck, U.S . Food, Drug Administration, FDA Locations: U.S, London
0 next >>
Total: 2